Search
+
    SEARCHED FOR:

    NEPHRO CARE GMP

    Does NSE's price capping on SME IPOs mean no multibagger returns on Day 1?

    As SME IPOs gain traction among investors, regulators are moving to formalise the market with stricter controls. The NSE recently imposed a cap on SME issue listing prices at 90%, independent of grey market trends. This impacted Nephro Care, which despite a 300% pre-listing GMP, debuted at only a 90% premium due to the exchange's price cap.

    Nephro Care shares list at 90% premium on NSE SME platform

    Nephro Care made a strong market debut on NSE SME platform with a 90% premium. The IPO garnered massive investor interest, oversubscribed by over 700 times. The company aims to establish a 100-bed multispeciality hospital in Kolkata using proceeds from the IPO. Nephro Care, led by Dr. Pratim Sengupta, focuses on comprehensive medical services for renal patients.

    Ambey Laboratories opens today: Check issue size, price band, GMP & other details

    Ambey Laboratories’ SME IPO, aiming to raise Rs 44.68 crore by July 8, offers shares at Rs 65-68 in lots of 2,000. With Rs 100 crore revenue and Rs 6.02 crore profit, it's set to list on NSE SME.

    Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status

    Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status

    Nephro Care IPO opens today: Check issue size, price band, GMP and other details

    Invest in the Nephro Care IPO in Kolkata to support healthcare initiatives and gain potential returns through shares.

    The Economic Times
    BACK TO TOP